ArticleInternational journal of endocrinology2012
Previous gestational diabetes mellitus and markers of cardiovascular risk.
Article in International journal of endocrinology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 81 citations in OpenAlex.
- Elevated iron status and risk of gestational diabetes mellitus: A systematic review and meta-analysis.Maternal & child nutrition · 2017Pooled it
- Serum homocysteine level and gestational diabetes mellitus: A meta-analysis.Journal of diabetes investigation · 2016Pooled it
- Metabolic syndrome risk after gestational diabetes: a systematic review and meta-analysis.PloS one · 2014Pooled it
- Association of adverse pregnancy outcomes with coronary microvascular dysfunction: a systematic review and meta-analysis.American journal of preventive cardiology · 2027Review
- Early Postpartum IL-10 and IL-37 Concentrations in Women with Gestational Diabetes Mellitus.Medical science monitor : international medical journal of experimental and clinical research · 2025Article
- Microarray Analysis of Differentially Expressed Genes in Peripheral Blood of Postpartum Women with Gestational Diabetes Mellitus and Type 2 Diabetes.Life (Basel, Switzerland) · 2025Article
- Cardiac Imaging in Women with Ischemic Heart Disease.Life (Basel, Switzerland) · 2023Review
- Maternal glucose levels and future risk of developing cardiovascular disease: a systematic review and meta-analysis protocol.BMJ open · 2023Article
- Obesity Affects Maternal and Neonatal HDL Metabolism and Function.Antioxidants (Basel, Switzerland) · 2023Article
- Potential mechanisms and modulators of food intake during pregnancy.Frontiers in nutrition · 2023Review
- Long-term cardiovascular outcomes of gestational diabetes mellitus: a prospective UK Biobank study.Cardiovascular diabetology · 2022Article
- Gender gap in annual preventive care services in France.EClinicalMedicine · 2022Article
- New Insights into Adipokines in Gestational Diabetes Mellitus.International journal of molecular sciences · 2022Review
- The influence of inflammation on cardiovascular disease in women.Frontiers in global women's health · 2022Review
- Fetal High-Density Lipoproteins: Current Knowledge on Particle Metabolism, Composition and Function in Health and Disease.Biomedicines · 2021Review
- Racial and ethnic disparities in chronic health conditions among women with a history of gestational diabetes mellitus.Health promotion perspectives · 2021Article
- Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use.Therapeutic advances in endocrinology and metabolism · 2021Review
- Metabolic syndrome markers and risk of hyperglycemia in pregnancy: a cross-sectional cohort study.Scientific reports · 2020Article
- The Association of Adverse Pregnancy Outcomes and Cardiovascular Disease: Current Knowledge and Future Directions.Current treatment options in cardiovascular medicine · 2020Article
- Obesity and cardiovascular disease in women.International journal of obesity (2005) · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of gestational diabetes mellitus (GDM) in the developed world has increased at an alarming rate over the last few decades. GDM has been shown to be associated with postpartum diabetes, insulin resistance, hypertension, and dyslipidemia. A history of previous GDM (pGDM), associated or not with any of these metabolic abnormalities, can increase the risk of developing not only type 2 diabetes mellitus but also cardiovascular disease (CVD) independent of a diagnosis of type 2 diabetes later in life. In this paper we discuss the relationship among inflammatory markers, metabolic abnormalities, and vascular dysfunction in women with pGDM. We also review the current knowledge on metabolic modifications occurring in normal pregnancy and the link between alterations of a normal metabolic state with the long-term maternal complications that may result in increased CVD risk. Our review of studies on pGDM prompts us to recommend that these women be considered a population at risk for later CVD events, which however could be avoided via the use of specially designed follow-up programs in the future.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.